Prevalence of Amphetamine-Type Stimulant Use and Related Factors among Methadone Maintenance Patients in Ho Chi Minh City Vietnam

A Cross-Sectional Study

Bibliographic Data

ID13913140
AuthorsNgoc Tu Le (Department of Disease Control and Prevention, Pasteur Institute of Ho Chi Minh City, Ho Chi Minh City, Vietnam), Khuong Quynh Long (0000-0002-1232-6230, Center for Population Health Science, Hanoi University of Public Health, Hanoi, Vietnam, corresponding author), Vu Thi Tuong (0000-0003-3651-3003, University of Medicine and Pharmacy at Ho Chi Minh City), Thi Tuong Vi Vu (Vietnam HIV Addiction Technology Transfer Center, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam), Truc Thanh Thai (0000-0003-2512-8281, University of Medicine and Pharmacy at Ho Chi Minh City), Huynh Thi Cam Hong Le (Vietnam HIV Addiction Technology Transfer Center, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam), Thang Phuoc Dao (0000-0001-6379-9831), Phuoc Thang Dao (Interactive Research and Development, Ho Chi Minh City, Vietnam), Sy Hieu Le (Woolcock Institute of Medical Research), Thi Thu Van Tieu (Prevention HIV/AIDS Center Ho Chi Minh City HIV/AIDS Association, Ho Chi Minh City, Vietnam), Do Van Dung (0000-0001-6872-3481, University of Medicine and Pharmacy at Ho Chi Minh City)
Year2021
Volume53
Issue4
Pages355-363
Publication date2021-01-27
Open AccessNo
TypeARTICLE
VenueJournal of Psychoactive Drugs (JOURNAL)
Journal identifiersISSN: 0279-1072 • E-ISSN: 2159-9777
PublisherTaylor & Francis (PUBLISHER • GB)
DOI10.1080/02791072.2020.1871126
PMID33504276
OpenAlexW3122896466
LanguageEN
Citations received3
References cited23

The objective of this study was to determine the prevalence of amphetamine-type stimulant use and associated factors among methadone maintenance treatment (MMT) patients. In 2018, a cross-sectional study was conducted on 967 MMT patients at two methadone clinics in Ho Chi Minh City that serve Vietnamese patients. Amphetamine-type stimulant use was assessed by rapid urine test and face-to-face interview using the Alcohol, Smoking, Substance Involvement Screening Test (ASSIST) tool. The prevalence of amphetamine-type stimulant use assessed by urine test was 25.4%. According to ASSIST, the prevalence of moderate and high risk amphetamine-type stimulant use was 15.5% and 1.1%, respectively. Amphetamine-type stimulant use and hazardous use were more prevalent in younger patients, having a part-time job, drug injection, having a lower score of self-health assessment, treated with a higher dose of methadone and missing methadone dose in the past 3 months. By contrast, patients who were HIV positive were less likely to use amphetamine-type stimulants. Cannabis and heroin use were significantly associated with amphetamine-type stimulant use (OR = 1.46; 95% CI: 1.38-8.67; and OR = 1.50; CI: 1.04-2.18, respectively) and hazardous use (OR = 4.07; CI: 1.67-9.92; and OR = 2.38; CI: 1.56-3.63, respectively). Screening and interventions are needed to cope with this issue on time, particularly in young patients, having drug injection and concurrent drugs user groups

Amphetamine · Cross-sectional study · Methadone · Methadone maintenance · Psychiatry · Stimulant · Forensic Toxicology and Drug Analysis · HIV, Drug Use, Sexual Risk · Medicine · Opioid Use Disorder Treatment · Internal Medicine

Tools

Open DOI